News about Global Pharma

Caliber Launches 4 AI-driven Solutions to Revolutionise Pharma Manufacturing

Caliber has launched four new digital solutions—CalGenie, CaliberMetrix, CaliberPulse, and CalWare360—reinforcing its leadership in Pharma 4.0 and advancing digital transformation.

Global Pharma | 13/03/2025 | By Manvi |  370

Zynext Ventures Backs Illexcor Therapeutics to Advance Novel Oral Therapy for Sickle Cell Disease

Zynext Ventures, the venture capital arm of Zydus Lifesciences, has invested in Illexcor Therapeutics to support the development of a novel oral therapy for sickle cell disease.

Global Pharma | 13/03/2025 | By Manvi |  417

BGS US Secures ISO Certifications for New Electron Beam Sterilisation Facility

The facility will begin operations in mid-2025.

Global Pharma | 13/03/2025 | By Abha |  220

Almac Group Unveils EUR 65M Commercial Manufacturing Facility in Northern Ireland

The new 100,000sq ft facility enhances existing capabilities in commercial manufacture of oral dose treatments for a variety of therapeutic areas.

Global Pharma | 13/03/2025 | By Abha |  532

Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin in India

Glenmark Pharmaceuticals has launched Empagliflozin, a widely recognised SGLT2 inhibitor under the brand Glempa, a range of Empagliflozin-based medications in India, offering advanced and affordable treatment options for type 2 diabetes mellitus with cardiovascular benefits.

Global Pharma | 12/03/2025 | By Manvi |  1407

SK bioscience Ships 750,000 Doses of SKYCellflu to Southern Hemisphere Markets

SK bioscience announced that the company has begun shipping its self-developed influenza vaccine, SKYCellflu, from its vaccine manufacturing facility L HOUSE to Southern Hemisphere markets, including Southeast Asia and Latin America.

Global Pharma | 12/03/2025 | By Manvi |  382

Exogenus Picks Lonza to Develop GMP-Compliant Process to Manufacture Exo-101

Exogenus Therapeutics specializes in the development of healthcare solutions based on extracellular vesicles, including exosomes and other nanotechnologies.

Global Pharma | 12/03/2025 | By Aishwarya |  504

OneSource Specialty Pharma Strengthens its Board with Key Independent Directors Appointment

The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others.

Global Pharma | 12/03/2025 | By Aishwarya |  690

Shilpa Medicare Gets SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets

Shilpa Medicare Ltd. had earlier completed phase-3 clinical studies of this novel product SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets.

Global Pharma | 12/03/2025 | By Aishwarya |  826

Mahajan Imaging & Labs Hosts Roundtable Conference on Integrated Diagnostics and Women Health

The roundtable explored key issues in women’s health, including cancer screening, mental well-being, and the role of integrated diagnostics in early disease detection.

Global Pharma | 12/03/2025 | By Aishwarya |  215